We are live on
!
Find out more
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
3 hedge funds and large institutions have $5K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% less funds holding
Funds holding: 27 → 3 (-24)
99% less capital invested
Capital invested by funds: $405K → $5K (-$400K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 23
Holders
3
Holders Change
-24
Holders Change %
-88.89%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$39.4K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$254K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$60K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 4 |
VF
Virtu Financial
New York
|
-$15K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$13K |